International Myeloma Society Workshop on Assessment of Response and Progression Criteria in Multiple Myeloma 2024

International Myeloma Society Workshop on Assessment of Response and Progression Criteria in Multiple Myeloma 2024

Regular price€40,00
/
Tax included. Shipping calculated at checkout.

  • Free Shipping on orders over 45$
  • In stock, ready to ship
  • Inventory on the way

International Myeloma Society Workshop on Assessment of Response and Progression Criteria in Multiple Myeloma 2024

Include: 9 videos, size: 4.04 GB
Target Audience: hematologists & oncologists
 Information:


​According to Leanne Richardson’s LinkedIn post, the IMS IMWG Multiple Myeloma Response Criteria Workshop took place in Paris in November 2024. The event focused on discussing and establishing new consensus criteria for clinical trials in multiple myeloma.​

Although publicly available sources do not provide specific details about this workshop, previous workshops of the International Multiple Myeloma Working Group (IMWG) have made important contributions to standardizing response and progression criteria in the treatment of multiple myeloma. For example, international consensus response criteria for multiple myeloma were published at previous workshops, aiming to improve reporting and comparison of results between different clinical trials.​
Nature

For the most up-to-date and detailed information about the conference in Paris in November 2024, you should visit the official website of the International Multiple Myeloma Society (IMS) or contact them directly.

  • Hematologists & Oncologists – Specialists involved in diagnosing and treating multiple myeloma.

  • Clinical Researchers & Scientists – Those working on new treatment strategies and response criteria for multiple myeloma.

  • Pharmaceutical & Biotech Industry Representatives – Companies developing new therapies and clinical trials.

  • Regulatory Experts & Policymakers – Authorities involved in approving and standardizing response criteria in clinical trials.

  • Medical Professionals & Fellows – Doctors and researchers looking to update their knowledge of response assessment in myeloma.


 

Topics:
  • Consensus Session – Response Criteria 2024.mp4
  • Session 1 – Monoclonal protein assessments – Response Criteria 2024.mp4
  • Session 2 – Bone marrow testing – Response Criteria 2024.mp4
  • Session 3 – Peripheral blood – Response Criteria 2024.mp4
  • Session 4 – Imaging for response assessment – Response Criteria 2024.mp4
  • Session 5 – Response assessmet in smoldering – Response Criteria 2024.mp4
  • Session 6 – Special situations – Response Criteria 2024.mp4
  • Session 7 – Defining Progression – Response Criteria 2024.mp4
  • Session 8 – Endpoints for clinical trial – Response Criteria 2024.mp4

- Orders under 45$ will have a shipping charge of a flat rate of 15$.

-Orders over 45$ will have Free Shipping.

This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.

Testimonials

★★★★★


“I find the taste of Moringa tea to be very refreshing and it definitely gives me a feeling of ‘wellness’. I appreciate the ethics of the company. Am looking forward to trying the cream”

Elain
★★★★★


”I love knowing that everything is 100% chemical-free and tested in Canada. I also respect the sustainable farming approach that supports both Canada and Ethiopia.”

Alycia
★★★★★

Since I drink Moringa Tea I feel so much better. My mouth was always so dry but since I drink this tea I have so much saliva I drool.

I cannot believe how much it has helped me with my breathing. I love it. I even eat all the leaves - Thank you for introducing me to this herbal tea. I'm 85 years old.

Richard Dorge
Winnipeg, MB

Recently viewed